Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

11.8K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.8K
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

5.6K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

933
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
933
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial Transmembrane β-Barrels: Deducing Thermodynamic Regulators of Folding and Stability.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Decoding Outer Membrane β-Barrels: From Structural Curiosity to Engineered Nanotherapeutics.

Chemical reviews·2026
Same author

Linking multipoint folding and stability with functional regulation in the mitochondrial transmembrane β-barrel Sam50.

Nature communications·2026
Same author

Protein-lipid interplay governs ion channel gating and bioenergetics in human mitochondrial VDAC3.

Protein science : a publication of the Protein Society·2026
Same author

Lipid-regulated assembly mechanisms and functional energetics of the essential bacterial chaperone BamA.

Chemical science·2025
Same author

Hepatic Encephalopathy: Insights Into the Impact of Metabolic Precipitates.

Developmental neurobiology·2025

Related Experiment Video

Updated: Jan 7, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.1K

Synuclein and Mitochondrial Dysfunction: Regulating the Protein Import Complex toward PD Treatment?

Udit Kumar Dash1, Radhakrishnan Mahalakshmi1

  • 1Molecular Biophysics Laboratory, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal 462066, India.

ACS Chemical Neuroscience
|December 27, 2025
PubMed
Summary
This summary is machine-generated.

Parkinson's disease involves alpha-synuclein (αSyn) misimport into mitochondria via the TOM complex, leading to neuronal death. Targeting this interaction may offer new Parkinson's disease therapeutics.

Keywords:
Parkinson’s diseasesTOM complexaggregation blockersmitochondrial misimportneurotoxic plaquesynuclein

More Related Videos

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.3K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.3K

Related Experiment Videos

Last Updated: Jan 7, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.1K
Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.3K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.3K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder with motor symptoms linked to dopaminergic neuron loss.
  • Alpha-synuclein (αSyn) aggregation into Lewy bodies is a hallmark of PD.
  • Mitochondrial dysfunction is critical in PD pathogenesis, connecting αSyn to neuronal death.

Purpose of the Study:

  • To elucidate the mechanisms of αSyn misimport into mitochondria.
  • To investigate the role of the Translocase of the Outer Mitochondrial Membrane (TOM) complex in αSyn misimport.
  • To explore therapeutic strategies targeting the TOM-αSyn interaction for neurodegeneration.

Main Methods:

  • Review of recent findings on αSyn and TOM complex regulators.
  • Analysis of TOM-αSyn interaction mechanisms.
  • Examination of outcomes on mitochondrial dynamics.

Main Results:

  • The TOM complex can misimport αSyn into mitochondria.
  • TOM-αSyn interplay disrupts calcium homeostasis, ATP production, and increases reactive oxygen species.
  • This leads to mitochondrial dysfunction and dopaminergic neuron cell death.

Conclusions:

  • The TOM-αSyn interaction is a key driver of mitochondrial dysfunction in PD.
  • Understanding this interplay is crucial for developing therapeutics.
  • Targeting TOM-αSyn association could restore mitochondrial homeostasis and treat neurodegenerative conditions.